The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
Hypermethylation of the human telomerase catalytic subunit (hTERT) gene correlates with telomerase activity
Open accessAbstract
DNA methylation is an epigenetic process involved in embryonic development, differentiation and aging. It is 1 of the mechanisms resulting in gene silencing in carcinogenesis, especially in tumor suppressor genes (e.g., p16, Rb). Telomerase, the DNA polymerase adding TTAGGG repeats to the chromosome end, is involved in the regulation of the replicative life span by maintaining telomere length. This enzyme is activated in germ and stem cells, repressed in normal somatic cells and reactivated in a large majority of tumor cells. The promoter region of the hTERT gene, encoding for the catalytic subunit of human telomerase, has been located in a CpG island and may therefore be regulated at least in part by DNA methylation. We analyzed the methylation status of 27 CpG sites within the hTERT promoter core region by methylation‐sensitive single‐strand conformation analysis (MS‐SSCA) and direct sequencing using bisulfite‐modified DNA in 56 human tumor cell lines, as well as tumor and normal tissues from different organs. A positive correlation was observed among hypermethylation of the hTERT promoter, hTERT mRNA expression and telomerase activity (p < 0.00001). Furthermore, this correlation was confirmed in normal tissues where hypermethylation of the hTERT promoter was found exclusively in hTERT‐expressing telomerase‐positive samples and was absent in telomerase‐negative samples (p < 0.00002). Since tumor tissues contain also nonneoplastic stromal elements, we performed microdissection to allow confirmation that the hTERT promoter methylation truly occurred in tumor cells. Our results suggest that methylation may be involved in the regulation of hTERT gene expression. To our knowledge, this is the first gene in which methylation of its promoter sequence has been found to be positively correlated with gene expression. © 2002 Wiley‐Liss, Inc.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“There is a strong correlation between hTERT expression and TA, and recent studies have linked hTERT promoter hypermethylation to CRC and other cancer types [206].”
From Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy (2024) · cites this paper as [206]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands.
Herman, J. G., Graff, J. R., Myöhänen, S., Nelkin, B. D., & Baylin, S. B. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9821 · Cited by 5,634
Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription
Jones, P. L., Veenstra, G. J. C., Wade, P. A., Vermaak, D., Kass, S. U., Landsberger, N., Strouboulis, J., & Wolffe, A. P. (1998) · Nature Genetics · doi:10.1038/561 · Cited by 2,791
Alterations in DNA Methylation: A Fundamental Aspect of Neoplasia
Baylln, S. B., Herman, J. G., Graff, J. R., Vertino, P. M., & Issa, J. J. (1997) · Advances in cancer research · doi:10.1016/s0065-230x(08)60702-2 · Cited by 1,919
MeCP2 Is a Transcriptional Repressor with Abundant Binding Sites in Genomic Chromatin
Nan, X., Campoy, F. J., & Bird, A. P. (1997) · Cell · doi:10.1016/s0092-8674(00)81887-5 · Cited by 1,288
Weinrich, S. L., Pruzan, R., Ma, L., Ouellette, M. M., Tesmer, V. M., Holt, S. E., Bodnar, A. G., Lichtsteiner, S., Kim, N. W., Trager, J. B., et al. (1997) · Nature Genetics · doi:10.1038/ng1297-498 · Cited by 975
The essentials of DNA methylation
Bird, A. (1992) · Cell · doi:10.1016/0092-8674(92)90526-i · Cited by 948
Direct activation of TERT transcription by c-MYC
Wu, K.-J., Grandori, C., Amacker, M., Simon-Vermot, N., Polack, A., Lingner, J., & Dalla-Favera, R. (1999) · Nature Genetics · doi:10.1038/6010 · Cited by 893
Telomere maintenance by recombination in human cells
Dunham, M. A., Neumann, A. A., Fasching, C. L., & Reddel, R. R. (2000) · Nature Genetics · doi:10.1038/82586 · Cited by 879
DNA methylation inhibits transcription indirectly via a methyl-CpG binding protein
Boyes, J., & Bird, A. P. (1991) · Cell · doi:10.1016/0092-8674(91)90267-3 · Cited by 733
High levels of De Novo methylation and altered chromatin structure at CpG islands in cell lines
Antequera, F., Boyes, J., & Bird, A. P. (1990) · Cell · doi:10.1016/0092-8674(90)90015-7 · Cited by 696
Flagged first, then by citations
Cited by
Sorted by citations
Folate and DNA Methylation: A Review of Molecular Mechanisms and the Evidence for Folate's Role
Crider, K. S., Yang, T. P., Berry, R. J., & Bailey, L. B. (2012) · Advances in Nutrition · doi:10.3945/an.111.000992 · Cited by 1,055
The relationship between COPD and lung cancer
Durham, A. L., & Adcock, I. M. (2015) · Lung Cancer · doi:10.1016/j.lungcan.2015.08.017 · Cited by 456
Sulforaphane Causes Epigenetic Repression of hTERT Expression in Human Breast Cancer Cell Lines
Meeran, S. M., Patel, S. N., & Tollefsbol, T. O. (2010) · PLoS ONE · doi:10.1371/journal.pone.0011457 · Cited by 372
Understanding and exploiting hTERT promoter regulation for diagnosis and treatment of human cancers
Kyo, S., Takakura, M., Fujiwara, T., & Inoue, M. (2008) · Cancer Science · doi:10.1111/j.1349-7006.2008.00878.x · Cited by 347
TERT—Regulation and Roles in Cancer Formation
Dratwa, M., Wysoczańska, B., Łacina, P., Kubik, T., & Bogunia‐Kubik, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.589929 · Cited by 331
Promoter DNA Hypermethylation and Paradoxical Gene Activation
Smith, J., Sen, S., Weeks, R. J., Eccles, M. R., & Chatterjee, A. (2020) · Trends in cancer · doi:10.1016/j.trecan.2020.02.007 · Cited by 268
Mechanisms of human telomerase reverse transcriptase (hTERT) regulation: clinical impacts in cancer
Leao, R. R. N., Apolónio, J. D., Lee, D., Figueiredo, A., Tabori, U. Y., & Castelo‐Branco, P. (2018) · Journal of Biomedical Science · doi:10.1186/s12929-018-0422-8 · Cited by 273
Impact on DNA Methylation in Cancer Prevention and Therapy by Bioactive Dietary Components
Li, Y.-C., & Tollefsbol, T. O. (2010) · Current Medicinal Chemistry · doi:10.2174/092986710791299966 · Cited by 259
Castelo‐Branco, P., Choufani, S., Mack, S. C., Gallagher, D., Zhang, C., Lipman, T., Zhukova, N., Walker, E. J., Martin, D. C., Merino, D. M., et al. (2013) · The Lancet Oncology · doi:10.1016/s1470-2045(13)70110-4 · Cited by 261
Telomerase regulation and stem cell behaviour
Flores, I., Benetti, R., & Blasco, M. A. (2006) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2006.03.003 · Cited by 232
Differential hypermethylation of SOCS genes in ovarian and breast carcinomas
Sutherland, K. D., Lindeman, G. J., Choong, D. Y. H., Wittlin, S., Brentzell, L., Phillips, W., Campbell, I. G., & Visvader, J. E. (2004) · Oncogene · doi:10.1038/sj.onc.1207787 · Cited by 217
Zinn, R. L., Pruitt, K., Eguchi, S., Baylin, S. B., & Herman, J. G. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3396 · Cited by 210
Kim, W., Ludlow, A. T., Min, J., Robin, J. D., Stadler, G., Mender, I., Lai, T., Zhang, N., Wright, W. E., & Shay, J. W. (2016) · PLoS Biology · doi:10.1371/journal.pbio.2000016 · Cited by 223
Renaud, S., Loukinov, D. I., Abdullaev, Z., Guilleret, I., Bosman, F. T., Lobanenkov, V. V., & Benhattar, J. (2007) · Nucleic Acids Research · doi:10.1093/nar/gkl1125 · Cited by 211
Self-citationGenistein depletes telomerase activity through cross‐talk between genetic and epigenetic mechanisms
Li, Y., Liu, L., Andrews, L. G., & Tollefsbol, T. O. (2009) · International Journal of Cancer · doi:10.1002/ijc.24398 · Cited by 195
Chronic obstructive pulmonary disease (COPD) and lung cancer: common pathways for pathogenesis
Parris, B. A., O’Farrell, H. E., Fong, K. M., & Yang, I. A. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.10.54 · Cited by 196
DNA hypermethylation within TERT promoter upregulates TERT expression in cancer
Lee, D. D., Leao, R. R. N., Komosa, M., Gallo, M., Zhang, C. H., Lipman, T., Remke, M., Heidari, A., Nunes, N. M., Apolónio, J. D., et al. (2018) · Journal of Clinical Investigation · doi:10.1172/jci121303 · Cited by 194
Aging, cancer and nutrition: the DNA methylation connection
Liu, L., Wylie, R. C., Andrews, L. G., & Tollefsbol, T. O. (2003) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2003.08.001 · Cited by 171
Epigenetic Control of Gene Expression in the Lung
Yang, I. V., & Schwartz, D. A. (2011) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.201010-1579pp · Cited by 169
Pathology and molecular biology of gastric cancer
Vauhkonen, M., Vauhkonen, H., & Sipponen, P. (2006) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2006.03.016 · Cited by 154
Long telomeres and cancer risk: the price of cellular immortality
McNally, E. J., Luncsford, P. J., & Armanios, M. Y. (2019) · Journal of Clinical Investigation · doi:10.1172/jci120851 · Cited by 154
Transcription Regulation of the Human Telomerase Reverse Transcriptase (hTERT) Gene
Ramlee, M. K., Wang, J., Toh, W. H., & Li, S. (2016) · Genes · doi:10.3390/genes7080050 · Cited by 157
TERT promoter mutations are associated with poor prognosis and cell immortalization in meningioma
Spiegl‐Kreinecker, S., Lötsch, D., Neumayer, K., Kastler, L., Gojo, J., Pirker, C., Pichler, J., Weis, S., Kumar, R., Webersinke, G., et al. (2018) · Neuro-Oncology · doi:10.1093/neuonc/noy104 · Cited by 148
Genomic footprints of activated telomere maintenance mechanisms in cancer
Sieverling, L., Hong, C., Koser, S. D., Ginsbach, P., Kleinheinz, K., Hutter, B., Braun, D. M., Cortés‐Ciriano, I., Xi, R., Kabbe, R., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13824-9 · Cited by 141
Telomere Maintenance Mechanisms in Cancer
Gaspar, T. B., Sá, A., Lopes, J. M., Sobrinho-Simões, M. A., Soares, P., & Vinagre, J. (2018) · Genes · doi:10.3390/genes9050241 · Cited by 144
Dioni, L., Hoxha, M., Nordio, F., Bonzini, M., Tarantini, L., Albetti, B., Savarese, A., Schwartz, J. D., Bertazzi, P. A., Apostoli, P., et al. (2010) · Environmental Health Perspectives · doi:10.1289/ehp.1002486 · Cited by 127
de Mendoza, A., Nguyen, T. V., Ford, E., Poppe, D., Buckberry, S., Pflueger, J., Grimmer, M., Stolzenburg, S., Bogdanović, O., Oshlack, A., et al. (2022) · Genome biology · doi:10.1186/s13059-022-02728-5 · Cited by 130
Genetic and epigenetic modulation of telomerase activity in development and disease
Liu, L., Lai, S. R., Andrews, L. G., & Tollefsbol, T. O. (2004) · Gene · doi:10.1016/j.gene.2004.06.011 · Cited by 123
Clément, G., Braunschweig, R., Pasquier, N., Bosman, F. T., & Benhattar, J. (2005) · The Journal of Pathology · doi:10.1002/path.1884 · Cited by 121
Self-citationKeyes, M. K., Jang, H., Mason, J. B., Liu, Z., Crott, J. W., Smith, D. E., Friso, S., & Choi, S. (2007) · Journal of Nutrition · doi:10.1093/jn/137.7.1713 · Cited by 116
On the road to immortality: hTERT upregulation in cancer cells
Janknecht, R. (2004) · FEBS Letters · doi:10.1016/s0014-5793(04)00356-4 · Cited by 118
TERT promoter mutations contribute to subset prognostication of lower-grade gliomas
Chan, A. K., Yao, Y., Zhang, Z., Chung, N. Y., Liu, J. S.-M., Li, K. K., Shi, Z., Chan, D. T. M., Poon, W. S., Zhou, L., et al. (2014) · Modern Pathology · doi:10.1038/modpathol.2014.94 · Cited by 111
Guilleret, I., & Benhattar, J. (2003) · Experimental Cell Research · doi:10.1016/s0014-4827(03)00281-7 · Cited by 110
DNA and histone methylation in gastric carcinogenesis
Calcagno, D. Q. (2013) · World Journal of Gastroenterology · doi:10.3748/wjg.v19.i8.1182 · Cited by 111
Regulation of Telomerase and Telomeres: Human Tumor Viruses Take Control
Bellon, M., & Nicot, C. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djm269 · Cited by 104
Telomerase Regulation: A Role for Epigenetics
Doğan, F., & Forsyth, N. R. (2021) · Cancers · doi:10.3390/cancers13061213 · Cited by 107
Kang, H.-J., Cui, Y., Yin, H., Scheid, A., Hendricks, W. P. D., Schmidt, J. E., Sekulić, A., Kong, D., Trent, J. M., Gokhale, V. M., et al. (2016) · Journal of the American Chemical Society · doi:10.1021/jacs.6b07598 · Cited by 100
Immunohistochemical localization of hTERT protein in human tissues
Seelentag, W. K. F., Stehle, J., Bosman, F. T., Yan, P., & Benhattar, J. (2004) · Histochemistry and Cell Biology · doi:10.1007/s00418-004-0645-5 · Cited by 94
Self-citationTelomerase in Cancer: Function, Regulation, and Clinical Translation
Robinson, N. J., & Schiemann, W. P. (2022) · Cancers · doi:10.3390/cancers14030808 · Cited by 105
Telomeres and telomerase as targets for anticancer drug development
Olaussen, K. A., Dubrana, K., Dômont, J., Spano, J., Sabatier, L., & Soria, J. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2005.08.007 · Cited by 96
Influence of age on wound healing and fibrosis
Kapetanaki, M. G., Mora, A. L., & Rojas, M. M. (2012) · The Journal of Pathology · doi:10.1002/path.4122 · Cited by 92
Unusual distribution of DNA methylation within the hTERT CpG island in tissues and cell lines
Guilleret, I., & Benhattar, J. (2004) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.10.137 · Cited by 81
Self-citationChromatin and epigenetic regulation of the telomerase reverse transcriptase gene
Zhu, J., Zhao, Y., & Wang, S. (2010) · Protein & Cell · doi:10.1007/s13238-010-0014-1 · Cited by 81
Li, Y., & Tollefsbol, T. O. (2016) · Epigenomics · doi:10.2217/epi-2016-0078 · Cited by 72
Arita, H., Narita, Y., Takami, H., Fukushima, S., Matsushita, Y., Yoshida, A., Miyakita, Y., Ohno, M., Shibui, S., & Ichimura, K. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1203-9 · Cited by 74
Telomeres and telomerase in prostatic intraepithelial neoplasia and prostate cancer biology
Meeker, A. K. (2006) · Urologic Oncology Seminars and Original Investigations · doi:10.1016/j.urolonc.2005.11.002 · Cited by 74
Widschwendter, A., Müller, H. M., Hubalek, M., Wiedemair, A., Fiegl, H., GOEBEL, G., Mueller‐Holzner, E., Marth, C., & Widschwendter, M. (2004) · Gynecologic Oncology · doi:10.1016/j.ygyno.2004.01.036 · Cited by 70
Keratin 23 promotes telomerase reverse transcriptase expression and human colorectal cancer growth
Zhang, N., Zhang, R., Zou, K., Yu, W., Guo, W., Gao, Y., Li, J., Li, M., Tai, Y., Huang, W., et al. (2017) · Cell Death and Disease · doi:10.1038/cddis.2017.339 · Cited by 67
Gene-Specific Targeting of DNA Methylation in the Mammalian Genome
Urbano, A., Smith, J., Weeks, R. J., & Chatterjee, A. (2019) · Cancers · doi:10.3390/cancers11101515 · Cited by 67
MCAF1/AM Is Involved in Sp1-mediated Maintenance of Cancer-associated Telomerase Activity
Liu, L., Ishihara, K., Ichimura, T., Fujita, N., Hino, S., Tomita, S., Watanabe, S., Saitoh, N., Ito, T., & Nakao, M. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m807098200 · Cited by 66
Shin, K.-H., Kang, M., Dicterow, E., & Park, N.-H. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601291 · Cited by 74
Liu, L., Saldanha, S. N., Pate, M. S., Andrews, L. G., & Tollefsbol, T. O. (2004) · Genes Chromosomes and Cancer · doi:10.1002/gcc.20058 · Cited by 67
Chistiakov, D. A., Orekhov, A. N., & Bobryshev, Y. V. (2016) · International Journal of Cardiology · doi:10.1016/j.ijcard.2016.11.204 · Cited by 63
hTERT promoter activity and CpG methylation in HPV-induced carcinogenesis
de Wilde, J., Kooter, J. M., Overmeer, R., Claassen-Kramer, D., Meijer, C. J. L. M., Snijders, P. J. F., & Steenbergen, R. D. M. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-271 · Cited by 67
Renaud, S., Loukinov, D. I., Alberti, L., Vostrov, A. A., Kwon, Y., Bosman, F. T., Lobanenkov, V. V., & Benhattar, J. (2010) · Nucleic Acids Research · doi:10.1093/nar/gkq827 · Cited by 67
Self-citationShukla, S., Khan, S. U., Kumar, S., Sinha, S., Farhan, M., Bora, H. K., Maurya, R., & Meeran, S. M. (2015) · Cancer Prevention Research · doi:10.1158/1940-6207.capr-14-0286 · Cited by 62
Telomeres and Telomerase in the Development of Liver Cancer
der Stroth, L. I., Tharehalli, U., Güneş, Ç., & Lechel, A. (2020) · Cancers · doi:10.3390/cancers12082048 · Cited by 66
Hong, H. X., Zhang, Y. M., Xu, H., Su, Z., & Sun, P. (2007) · Molecules and Cells · doi:10.1016/s1016-8478(23)07351-x · Cited by 61
Ge, Z., Li, W., Wang, N., Liu, C., Zhu, Q., Björkholm, M., Gruber, A., & Xu, D. (2009) · The FASEB Journal · doi:10.1096/fj.09-140087 · Cited by 59
POT1-TPP1 telomere length regulation and disease
Aramburu, T. M., Plucinsky, S. M., & Skordalakes, E. (2020) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2020.06.040 · Cited by 58
Recent advances in telomere biology: implications for human cancer
Meeker, A. K., & De Marzo, A. M. (2004) · Current Opinion in Oncology · doi:10.1097/00001622-200401000-00007 · Cited by 56
Eldholm, V., Haugen, A., & Zienolddiny, S. (2013) · International Journal of Cancer · doi:10.1002/ijc.28570 · Cited by 56
Ohba, S., Mukherjee, J., Johannessen, T.-C. A., Mancini, A., Chow, T. T., Wood, M. D., Jones, L. E., Mazor, T., Marshall, R. E., Viswanath, P., et al. (2016) · Cancer Research · doi:10.1158/0008-5472.can-16-0696 · Cited by 55
TERT aberrancies: a screening tool for malignancy in follicular thyroid tumours
Paulsson, J. O., Mu, N., Shabo, I., Wang, N., Zedenius, J., Larsson, C., & Juhlin, C. C. (2018) · Endocrine Related Cancer · doi:10.1530/erc-18-0050 · Cited by 57
BORIS: a key regulator of cancer stemness
Soltanian, S., & Dehghani, H. (2018) · Cancer Cell International · doi:10.1186/s12935-018-0650-8 · Cited by 54
The Solo Play of TERT Promoter Mutations
Hafezi, F., & Perez-Bercoff, D. (2020) · Cells · doi:10.3390/cells9030749 · Cited by 54
Li, C.-T., Hsiao, Y., Wu, T., Lin, Y. L., Yeh, K., & Ko, J. (2011) · Journal of Cellular Biochemistry · doi:10.1002/jcb.23229 · Cited by 53
Kumari, A., Srinivasan, R., Vasishta, R. K., & Wig, J. D. (2009) · Annals of Surgical Oncology · doi:10.1245/s10434-009-0333-8 · Cited by 53
Progress on the role of DNA methylation in aging and longevity
Xiao, F., Kong, Q., Perry, B., & He, Y. (2016) · Briefings in Functional Genomics · doi:10.1093/bfgp/elw009 · Cited by 51
Betaine supplementation attenuates atherosclerotic lesion in apolipoprotein E-deficient mice
Lv, S., Fan, R., Du, Y., Hou, M., Tang, Z., Ling, W., & Zhu, H. (2009) · European Journal of Nutrition · doi:10.1007/s00394-009-0003-4 · Cited by 54
Farahzadi, R., Fathi, E., Mesbah‐Namin, S. A., & Zarghami, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188052 · Cited by 52
RetractedOzair, A., Bhat, V., Alisch, R. S., Khosla, A. A., Kotecha, R. R., Odia, Y., McDermott, M. W., & Ahluwalia, M. S. (2023) · Cancers · doi:10.3390/cancers15041342 · Cited by 51
Durham, A. L., Wiegman, C., & Adcock, I. M. (2011) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2011.03.006 · Cited by 53
Micronutrient status and global DNA methylation in school-age children
Perng, W., Rozek, L. S., Mora‐Plazas, M., Duchin, O., Marín, C., Forero, Y., Baylín, A., & Villamor, E. (2012) · Epigenetics · doi:10.4161/epi.21915 · Cited by 52
Folate deficiency as predisposing factor for childhood leukaemia: a review of the literature
Cantarella, C. D., Ragusa, D., Giammanco, M., & Tosi, S. (2017) · Genes & Nutrition · doi:10.1186/s12263-017-0560-8 · Cited by 52
Wang, N., Kjellin, H., Sofiadis, A., Fotouhi, O., Juhlin, C. C., Bäckdahl, M., Zedenius, J., Xu, D., Lehtiö, J., & Larsson, C. (2016) · Oncotarget · doi:10.18632/oncotarget.7237 · Cited by 50
Epigenetic mechanisms underlying arsenic-associated lung carcinogenesis
Breda, S. G. J. V., Claessen, S. M. H., Lo, K. C., van Herwijnen, M. H. M., Brauers, K. J. J., Lisanti, S., Theunissen, D. H. J., Jennen, D. G. J., Gaj, S., de Kok, T. M. C. M., et al. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1351-2 · Cited by 47
Sulforaphane modulates telomerase activity via epigenetic regulation in prostate cancer cell lines
Abbas, A., Hall, J. A., Patterson, W. L., Ho, E., Hsu, A., Al‐Mulla, F., & Georgel, P. T. (2015) · Biochemistry and Cell Biology · doi:10.1139/bcb-2015-0038 · Cited by 46
Epigenetic control of telomerase and modes of telomere maintenance in aging and abnormal systems
Serene, R. L. (2005) · Frontiers in bioscience · doi:10.2741/1661 · Cited by 46
Ellingsen, E. B., Mangsbo, S. M., Hovig, E. J., & Gaudernack, G. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.682492 · Cited by 46
hTERTmethylation and expression in gastric cancer
Gigek, C. O., Leal, M. F., Silva, P. N., Lisboa, L. C. F., Lima, E. M., Calcagno, D. Q., de Assumpção, P. P., Burbano, R. M. R., & Smith, M. D. A. C. (2009) · Biomarkers · doi:10.3109/13547500903225912 · Cited by 43
A column method for determination of DNA cytosine-C5-methyltransferase activity
Kim, B., Kwon, O. S., Joo, S. A., Park, J. A., Heo, K. Y., Kim, M. S., & Ahn, J. S. (2004) · Analytical Biochemistry · doi:10.1016/j.ab.2003.11.009 · Cited by 43
Takasawa, K., Arai, Y., Yamazaki‐Inoue, M., Toyoda, M., Akutsu, H., Umezawa, A., & Nishino, K. (2017) · Human Cell · doi:10.1007/s13577-017-0190-x · Cited by 42
Lee, J. C., Solomon, D. A., & Tihan, T. (2017) · Journal of Neuro-Oncology · doi:10.1007/s11060-016-2349-9 · Cited by 45
TERT, a promoter of CNS malignancies
Patel, B., Taiwo, R., Kim, A. H., & Dunn, G. P. (2020) · Neuro-Oncology Advances · doi:10.1093/noajnl/vdaa025 · Cited by 41
Bougel, S., Lhermitte, B., Gallagher, G., Flaugergues, J. C., Janzer, R. C., & Benhattar, J. (2013) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1246 · Cited by 39
Self-citationWilson, S. L., Liu, Y., & Robinson, W. P. (2016) · Placenta · doi:10.1016/j.placenta.2016.10.001 · Cited by 40
Zhang, X., Li, B., de Jonge, N., Björkholm, M., & Xu, D. (2015) · Oncotarget · doi:10.18632/oncotarget.2917 · Cited by 38
Santourlidis, S., Wernet, P., Ghanjati, F., Graffmann, N., Springer, J., Kriegs, C., Zhao, X., Brands, J., Araúzo-Bravo, M. J., Neves, R. P., et al. (2010) · Stem Cell Research · doi:10.1016/j.scr.2010.08.003 · Cited by 38
He, Y., Wu, Y., He, X., Liu, F. J., He, X., & Zhang, Y. (2009) · Theriogenology · doi:10.1016/j.theriogenology.2009.01.012 · Cited by 37
Current and Future Trends of Colorectal Cancer Treatment: Exploring Advances in Immunotherapy
Nikolouzakis, T. K., Chrysos, E., Docea, A. O., Fragkiadaki, P., Souglakos, J., Tsiaoussis, J., & Tsatsakis, A. (2024) · Cancers · doi:10.3390/cancers16111995 · Cited by 37
Gojo, J., Lötsch, D., Spiegl‐Kreinecker, S., Pajtler, K. W., Neumayer, K., Korbel, P., Araki, A., Brandstetter, A., Mohr, T. T., Hovestadt, V., et al. (2017) · Neuro-Oncology · doi:10.1093/neuonc/nox027 · Cited by 38
Methylation of CpG island promoters in uveal melanoma
Moulin, A., Clément, G., Bosman, F. T., Zografos, L., & Benhattar, J. (2008) · British Journal of Ophthalmology · doi:10.1136/bjo.2007.127035 · Cited by 37
Self-citationTelomerase as a new target for the treatment of hormone-refractory prostate cancer
Biroccio, A., & Leonetti, C. (2004) · Endocrine Related Cancer · doi:10.1677/erc.1.00764 · Cited by 37
Long, W. S., Zeng, Y., Zheng, B., Li, Y., Wang, Y., Chan, K., She, M., Lu, Y., Cao, C., & Wong, W. (2024) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.4c01255 · Cited by 37
Tao, S. (2012) · World Journal of Gastroenterology · doi:10.3748/wjg.v18.i19.2334 · Cited by 34
Wang, S., Hu, C., & Zhu, J. (2006) · Molecular Biology of the Cell · doi:10.1091/mbc.e06-09-0840 · Cited by 34
Chatagnon, A., Bougel, S., Perriaud, L., Lachuer, J., Benhattar, J., & Dante, R. (2008) · Carcinogenesis · doi:10.1093/carcin/bgn240 · Cited by 33
Self-citationJiang, J., Zhao, L., Zhao, C., Zhang, G., Zhao, Y., Li, J., Li, X., & Wei, L. (2011) · Gynecologic Oncology · doi:10.1016/j.ygyno.2011.11.023 · Cited by 33
Epigenetics in Asthma and Other Inflammatory Lung Diseases
Durham, A. L., Chou, P.-C., Kirkham, P., & Adcock, I. M. (2010) · Epigenomics · doi:10.2217/epi.10.27 · Cited by 34
Metadata
- Authors
- Guilleret, I., Yan, P., Grange, F., Braunschweig, R., Bosman, F. T., & Benhattar, J.
- Affiliations
- Centre Hospitalier Universitaire Vaudois (CH)
- Corresponding author
- Benhattar, Jean
- Venue
- International Journal of Cancer
- Publisher
- Wiley
- Published
- 2002-08-29
- Volume
- 101
- Issue
- 4
- Pages
- 335-341
- ISSN
- 0020-7136 (ISSN-L)
- 1097-0215
- OpenAlex
- W2055902044
- Cited by
- 260
- References
- 44
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 10 · 2023: 13 · 2022: 12 · 2021: 12 · 2020: 18 · 2019: 13 · 2018: 12 · 2017: 12 · 2016: 19 · 2015: 18 · 2014: 5 · 2013: 12 · 2012: 8
- FWCI
- 4.00
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- International Journal of Cancer (publishedVersion)
- PubMed (publishedVersion)
- IRIS (submittedVersion)
- SERVAL (Université de Lausanne) (submittedVersion)
- Funders
- National Science Foundation
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Telomeres, Telomerase, and Senescence
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Genomics and Chromatin Dynamics
- Keywords
- hTERT, telomerase, promoter hypermethylation, DNA methylation, CpG islands, telomerase activity, gene expression regulation, tumor suppressor, gene silencing, cancer cell lines, telomere length
- MeSH terms
- DNA-Binding Proteins, Humans, Neoplasms, Promoter Regions, Genetic, RNA, Messenger, Tumor Cells, Cultured, Gene Expression Regulation, Enzymologic, Polymorphism, Single-Stranded Conformational, Telomerase, DNA Methylation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review